MIRA PHARMACEUTICALS INC (MIRA) Stock Price, Quote, News and Overview
NASDAQ:MIRA - Nasdaq - US60458C1045 - Common Stock - Currency: USD
MIRA Quote, Performance and Key Statistics
1.1
-0.01 (-0.9%)
The current stock price of MIRA is 1.1 USD. In the past month the price decreased by -2.65%. In the past year, price increased by 10%.
MIRA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 67.21 | 829.40B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 27.53 | 390.99B | ||
| JNJ | JOHNSON & JOHNSON | 16.25 | 390.76B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 20.56 | 230.17B | ||
| MRK | MERCK & CO. INC. | 11.71 | 226.40B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.77 | 215.98B | ||
| PFE | PFIZER INC | 8.46 | 149.04B | ||
| SNY | SANOFI-ADR | 13.62 | 136.54B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 48.97 | 113.23B | ||
| GSK | GSK PLC-SPON ADR | 7.81 | 74.77B | ||
| ZTS | ZOETIS INC | 27.1 | 72.39B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.95 | 44.58B |
Related stock screener links
About MIRA
Company Profile
Mira Pharmaceuticals Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Miami, Florida and currently employs 3 full-time employees. The company went IPO on 2023-08-03. MIRA Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical development company. The firm has two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive license rights in the United States, Canada and Mexico for Ketamir-2, a patent pending oral ketamine analog under pre-clinical investigation to potentially deliver ultra-rapid antidepressant effects, providing hope for individuals battling treatment-resistant depression (TRD), major depressive disorder with suicidal ideation (MDSI) and potentially post-traumatic stress disorder (PTSD). Its oral pharmaceutical marijuana molecule, MIRA-55, is being studied for its potential to alleviate neuropathic pain, as well as anxiety and cognitive decline, symptoms commonly associated with early-stage dementia.
Company Info
MIRA PHARMACEUTICALS INC
1200 Brickell Avenue, Suite 1950 #1183
Miami FLORIDA US
Employees: 5
Company Website: https://mirapharmaceuticals.com/
Investor Relations: https://www.mirapharmaceuticals.com/investors
Phone: 18133695150
MIRA PHARMACEUTICALS INC / MIRA FAQ
What is the stock price of MIRA PHARMACEUTICALS INC today?
The current stock price of MIRA is 1.1 USD. The price decreased by -0.9% in the last trading session.
What is the ticker symbol for MIRA PHARMACEUTICALS INC stock?
The exchange symbol of MIRA PHARMACEUTICALS INC is MIRA and it is listed on the Nasdaq exchange.
On which exchange is MIRA stock listed?
MIRA stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for MIRA PHARMACEUTICALS INC stock?
8 analysts have analysed MIRA and the average price target is 12.33 USD. This implies a price increase of 1020.45% is expected in the next year compared to the current price of 1.1. Check the MIRA PHARMACEUTICALS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is MIRA PHARMACEUTICALS INC worth?
MIRA PHARMACEUTICALS INC (MIRA) has a market capitalization of 18.22M USD. This makes MIRA a Nano Cap stock.
How many employees does MIRA PHARMACEUTICALS INC have?
MIRA PHARMACEUTICALS INC (MIRA) currently has 5 employees.
What are the support and resistance levels for MIRA PHARMACEUTICALS INC (MIRA) stock?
MIRA PHARMACEUTICALS INC (MIRA) has a support level at 1.05 and a resistance level at 1.13. Check the full technical report for a detailed analysis of MIRA support and resistance levels.
Should I buy MIRA PHARMACEUTICALS INC (MIRA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MIRA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MIRA, evaluating the profitability, health, valuation and growth aspects
- MIRA PHARMACEUTICALS INC (MIRA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MIRA PHARMACEUTICALS INC (MIRA) Sales and EPS estimates to see what analysts future expectations are.
- MIRA PHARMACEUTICALS INC (MIRA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MIRA PHARMACEUTICALS INC (MIRA) Insider and Institutional Ownership to learn about the owners and their transactions.
- MIRA PHARMACEUTICALS INC (MIRA) Stock Chart to make your own analysis
- MIRA PHARMACEUTICALS INC (MIRA) Latest news and press-releases to stay up to date.
Does MIRA PHARMACEUTICALS INC (MIRA) stock pay dividends?
MIRA does not pay a dividend.
What is the Price/Earnings (PE) ratio of MIRA PHARMACEUTICALS INC (MIRA)?
MIRA PHARMACEUTICALS INC (MIRA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.73).
What is the Short Interest ratio of MIRA PHARMACEUTICALS INC (MIRA) stock?
The outstanding short interest for MIRA PHARMACEUTICALS INC (MIRA) is 4.62% of its float. Check the ownership tab for more information on the MIRA short interest.
MIRA Technical Analysis
MIRA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to MIRA. No worries on liquidiy or solvency for MIRA as it has an excellent financial health rating, but there are worries on the profitability.
MIRA Financial Highlights
Over the last trailing twelve months MIRA reported a non-GAAP Earnings per Share(EPS) of -0.73. The EPS increased by 20.66% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -263.45% | ||
| ROE | -314.53% | ||
| Debt/Equity | 0 |
MIRA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to MIRA. The Buy consensus is the average rating of analysts ratings from 8 analysts.